SRE vs SYRE · P/E 31, rev $13.70B vs $7.60B cap
Sempra Energy (SRE) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
SRE currently screens at market cap $59.76B and trailing P/E 31.1. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the SRE and SYRE stock pages for the full models.
Not investment advice.